The path forward for large language models in medicine is open.

Autor: Riedemann L; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. lars.riedemann@med.uni-heidelberg.de., Labonne M; Liquid AI, Inc., 314 Main St., Cambridge, MA, 02142, USA., Gilbert S; Else Kröner Fresenius Center for Digital Health, TUD Dresden University of Technology, Fetscherstr. 74, 01307, Dresden, Germany.

Publikováno v: NPJ digital medicine [NPJ Digit Med] 2024 Nov 27; Vol. 7 (1), pp. 339. Date of Electronic Publication: 2024 Nov 27.

Advancing digital health applications: priorities for innovation in real-world evidence generation.

Autor: Stern AD; Technology and Operations Management Unit, Harvard Business School, Boston, MA, USA; Health Innovation Hub, Berlin Germany; Digital Health Center, Hasso-Plattner Institute, Potsdam, Germany. Electronic address: astern@hbs.edu., Brönneke J; Health Innovation Hub, Berlin Germany., Debatin JF; Health Innovation Hub, Berlin Germany., Hagen J; Health Innovation Hub, Berlin Germany., Matthies H; Health Innovation Hub, Berlin Germany., Patel S; Digital Medicine Society (DiMe), Boston, MA, USA., Clay I; Digital Medicine Society (DiMe), Boston, MA, USA; Evidation Health, San Mateo, CA, USA., Eskofier B; Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Herr A; Institute of Health Economics, Department of Economics, Leibniz University Hannover, Hannover, Germany., Hoeller K; EIT Health, Erlangen, Germany., Jaksa A; Aetion, Boston, MA, USA., Kramer DB; Richard A and Susan F Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kyhlstedt M; Synergus RWE, Stockholm, Sweden., Lofgren KT; Foundation Medicine, Cambridge, MA, USA., Mahendraratnam N; Aetion, New York, NY, USA., Muehlan H; Psychological Institute, Department Health & Prevention, University of Greifswald, Greifswald, Germany., Reif S; Health Care Markets and Policy Group, ZEW - Leibniz Centre for European Economic Research, Mannheim, Germany., Riedemann L; Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany., Goldsack JC; Digital Medicine Society (DiMe), Boston, MA, USA.

Publikováno v: The Lancet. Digital health [Lancet Digit Health] 2022 Mar; Vol. 4 (3), pp. e200-e206.

Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?

Autor: Burth S; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Ohmann M; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Kronsteiner D; Institute of Medical Biometry and Informatics, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Kieser M; Institute of Medical Biometry and Informatics, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany., Löw S; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Riedemann L; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Laible M; Department of Neurology, Ulm University Hospital, Oberer Eselsberg 45, 89081, Ulm, Germany., Berberich A; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Drüschler K; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Rizos T; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Wick A; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Winkler F; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Wick W; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany., Nagel S; Department of Neurology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Simon.Nagel@med.uni-heidelberg.de.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2021 May; Vol. 152 (3), pp. 483-490. Date of Electronic Publication: 2021 Mar 05.

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases.

Autor: Berghoff AS; Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Clinical Cooperation Unit Neuro-Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Breckwoldt MO; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany., Riedemann L; Clinical Cooperation Unit Neuro-Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Karimian-Jazi K; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany., Loew S; Clinical Cooperation Unit Neuro-Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Schlieter F; Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Furtner J; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Cinci M; Department of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Thomas M; Department of Thoracic Oncology, University Hospital Heidelberg and Translational Lung Research Center Heidelberg, Heidelberg, Germany., Strowitzki MJ; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Marmé F; National Center for Tumor Disease, Gynecologic Oncology, University Hospital Heidelberg, Heidelberg, Germany., Michel LL; National Center for Tumor Disease, Gynecologic Oncology, University Hospital Heidelberg, Heidelberg, Germany., Schmidt T; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany., Jäger D; Department of Medical Oncology and Internal Medicine VI, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Bendszus M; Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany., Preusser M; Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Wick W; Clinical Cooperation Unit Neuro-Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany., Winkler F; Clinical Cooperation Unit Neuro-Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2020 Mar 16; Vol. 2 (1), pp. vdaa038. Date of Electronic Publication: 2020 Mar 16 (Print Publication: 2020).

Unveiling the Inflammatory Landscape of Recurrent Glioblastoma through Histological-Based Assessments.

Autor: Dadario, Nicholas B.¹ (AUTHOR) dmb2245@cumc.columbia.edu, Boyett, Deborah M.¹ (AUTHOR) det2130@cumc.columbia.edu, Teasley, Damian E.¹ (AUTHOR) pjc2194@cumc.columbia.edu, Chabot, Peter J.¹ (AUTHOR) njw2130@cumc.columbia.edu, Winans, Nathan J.¹ (AUTHOR) mga2122@cumc.columbia.edu, Argenziano, Michael G.¹ (AUTHOR) cps2155@cumc.columbia.edu, Sperring, Colin P.¹ (AUTHOR) pc561@cumc.columbia.edu, Canoll, Peter^1,2 (AUTHOR), Bruce, Jeffrey N.¹ (AUTHOR) nbd2122@cumc.columbia.edu

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3283. 22p.